ClinicalMetric tracks all active clinical trials for adhd sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — adhd Clinical Trials
How many clinical trials are currently recruiting for adhd?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for adhd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for adhd?
adhd research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a adhd clinical trial?
Eligibility criteria for adhd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06012903
Recruiting
Lower Urinary Tract Symptoms and School Functioning in Children
Enrollment
250 pts
Location
Belgium
Sponsor
University Hospital, Ghent
NCT05492422
Recruiting
Central Executive Training and Parent Training for ADHD
Enrollment
200 pts
Location
United States
Sponsor
Florida State University
NCT06142786
Recruiting
Individualized Alpha Neurofeedback for ADHD
Enrollment
60 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
NCT03425669
Recruiting
Acoustic and Vestibular Noise as Possible Non-pharmacological Treatment of ADHD in School Children
Enrollment
70 pts
Location
Sweden
Sponsor
Lund University
NCT06978452
Recruiting
Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories
Enrollment
560 pts
Location
Canada
Sponsor
Douglas Mental Health Universi...
NCT06808425
Recruiting
Intervention With Weighted Blankets for Children With ADHD and Sleep Problems: Implementation and Effectiveness
Enrollment
200 pts
Location
Sweden
Sponsor
Halmstad University
NCT06797726
Recruiting
Feasibility and Efficacy of Cognitive-Behavioral Therapy for Patients With ADHD/Behavioral Addiction Comorbidity
Enrollment
54 pts
Location
France
Sponsor
University Hospital, Tours
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology